ATXS vs NVST · rev $706.0K vs P/E 56, rev $1.44B
Astria Therapeutics Inc (ATXS) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
ATXS currently screens at market cap $382.1M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the ATXS and NVST stock pages for the full models.
Not investment advice.